Cantor Boosts Ligand Pharma Target To $93 By: Benzinga via Benzinga June 19, 2015 at 11:07 AM EDT In a report published Friday, Cantor Fitzgerald analyst Irina Rivkind Koffler maintained a Hold rating on Ligand Pharmaceuticals Inc. ... Read More >> Related Stocks: Ligand Pharm